568565-48-0

Upstream product

• 4559-70-0 Diphenylphosphine oxide 
• 170716-16-2 1,3,5-tris<(R)-(+)-phenylethyl>hexahydrotriazine 

Downstream Products

• 568565-46-8 (1R)-N-diphenylphosphinoylmethyl-N-methyl-N-1-phenylethylamine 
• 568565-44-6 (1R)-N-[(2-(2-isopropoxy-3-methoxy)phenyl)-4'-isopropoxyphenyl]vinyl-N-methyl-N-1-phenylethylamine 
• 568565-43-5 (1R,2S)-N-[2-((2-isopropoxy-3-methoxy)phenyl)-4'-isopropoxyphenyl]ethyl-N-methyl-N-1-phenylethylamine 
• 568565-51-5 (1R,2R)-N-[2-((2-isopropoxy-3-methoxy)phenyl)-4'-isopropoxyphenyl]ethyl-N-methyl-N-1-phenylethylamine 
• 612483-06-4 [(E)-2-(4-Benzyloxy-2-[1,3]dioxan-2-yl-5-methoxy-phenyl)-2-(4-benzyloxy-phenyl)-vinyl]-methyl-((R)-1-phenyl-ethyl)-amine 

Relevant academic research and scientific papers

Asymmetric synthesis of (+)- and (-)-latifine

A concise and novel synthesis of isoquinoline alkaloids (S)-latifine and of its antipode is reported. The key step relies on the stereoselective reduction of an appropriately substituted diarylenamine equipped with a chiral auxiliary followed by Pictet-Sp

A new synthesis of (+)- and (-)-cherylline.

A new and concise synthesis of enantiopure antipodes of alkaloid cherylline has been devised. The synthetic strategy relies upon the reduction of a diversely and polyprotected diarylenamine bearing a chiral auxiliary. Separation of diastereopure intermediates, concomitant deprotections and intramolecular reductive amination complete the synthesis of the natural (S)-enantiomer and of the unnatural (R)-configured antipode.